Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
17.05
-0.11 (-0.64%)
Jun 6, 2025, 3:04 PM CST
SHE:300181 Revenue
Zhejiang Jolly Pharmaceutical Co.,LTD had revenue of 824.43M CNY in the quarter ending March 31, 2025, with 22.52% growth. This brings the company's revenue in the last twelve months to 2.73B, up 28.77% year-over-year. In the year 2024, Zhejiang Jolly Pharmaceutical Co.,LTD had annual revenue of 2.58B with 32.71% growth.
Revenue (ttm)
2.73B
Revenue Growth
+28.77%
P/S Ratio
4.33
Revenue / Employee
1.28M
Employees
2,125
Market Cap
11.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.58B | 635.44M | 32.71% |
Dec 31, 2023 | 1.94B | 137.29M | 7.61% |
Jan 1, 2023 | 1.81B | 347.76M | 23.86% |
Jan 1, 2022 | 1.46B | 366.52M | 33.60% |
Dec 31, 2020 | 1.09B | 179.71M | 19.72% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |